GDV GABELLI DIVIDEND & INCOME TRUST
Price Chart
Executive Summary
The Gabelli Dividend & Income Trust filed an 8-K reporting that Mario J. Gabelli (Chairman, CIO, Trustee) was hospitalized after a medical incident on March 19, 2026. His condition is improving, but his return timeline is unknown. The fund's adviser, GAMCO, has activated its succession plan, with Christopher J. Marangi named President and day-to-day operations led by co-CEO Douglas R. Jamieson and Marangi. The portfolio management team is led by Co-CIOs Kevin V. Dreyer and Christopher J. Marangi during Gabelli's absence.
Actionable Insight
Monitor for further updates on Gabelli's health status and any changes to the succession plan. The orderly transition suggests limited near-term disruption, but prolonged absence could introduce key-person risk. No immediate trading trigger.
Key Facts
- Mario J. Gabelli was admitted to the hospital on March 19, 2026 after a medical incident.
- His condition is improving but the timeline for his return is not yet known.
- GAMCO's succession plan was implemented on March 22, 2026; Christopher J. Marangi named President.
- Day-to-day operations of GAMCO are led by co-CEO Douglas R. Jamieson and Christopher J. Marangi.
- The Fund's portfolio management team is led by Co-CIOs Kevin V. Dreyer and Christopher J. Marangi.
Financial Impact
No financial impact disclosed in the filing.
Risk Factors
- Key-person risk if Gabelli's absence extends significantly.
- Potential for management disruption if recovery is prolonged or if succession plan execution falters.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001829126-26-004781 |
| Document: 0001829126-26-004781-index-headers.html | 0001829126-26-004781 |
| Document: 0001829126-26-004781-index.html | 0001829126-26-004781 |
| Document: 0001829126-26-004781.txt | 0001829126-26-004781 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
6d ago
|
DEFA14A
| $17.69 awaiting T+5 | awaiting T+5 | — | $29.13 (+64.67%) |
|
Jun 5, 2026
9d ago
|
DEFA14A
| $17.55 awaiting T+5 | awaiting T+5 | — | $29.13 (+65.98%) |
|
May 29, 2026
16d ago
|
DEFA14A
| $17.63 $17.55 | ▼ −0.45% | ▲ +2.30% | $29.13 (+65.23%) |
|
May 27, 2026
18d ago
|
DEFA14A
| $17.68 $17.59 | ▼ −0.48% | ▼ −0.80% | $29.13 (+64.81%) |
|
May 26, 2026
19d ago
|
DEFA14A
| $17.65 $17.55 | ▼ −0.57% | ▼ −1.04% | $29.13 (+65.04%) |
|
May 22, 2026
23d ago
|
DEFA14A
| $17.65 $17.63 | ▼ −0.11% | ▼ −1.33% | $29.13 (+65.04%) |
|
May 13, 2026
4w ago
|
Press Release
| $29.05 $29.02 | ▼ −0.10% | ▲ +0.04% | $29.13 (+0.28%) |
|
May 7, 2026
5w ago
|
8-K
| $17.99 $17.84 | ▼ −0.84% | ▼ −2.30% | $29.13 (+61.92%) |
|
Apr 30, 2026
6w ago
|
DEFA14A
| $17.99 $17.99 | · 0.00% | ▼ −2.35% | $29.13 (+61.92%) |
|
Apr 23, 2026
7w ago
|
DEFA14A
| $17.96 $17.90 | ▼ −0.33% | ▼ −1.24% | $29.13 (+62.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access